rs326222
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000107.3(DDB2):c.1189-21T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.654 in 1,610,336 control chromosomes in the GnomAD database, including 354,776 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.58 ( 27322 hom., cov: 31)
Exomes 𝑓: 0.66 ( 327454 hom. )
Consequence
DDB2
NM_000107.3 intron
NM_000107.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.151
Genes affected
DDB2 (HGNC:2718): (damage specific DNA binding protein 2) This gene encodes a protein that is necessary for the repair of ultraviolet light-damaged DNA. This protein is the smaller subunit of a heterodimeric protein complex that participates in nucleotide excision repair, and this complex mediates the ubiquitylation of histones H3 and H4, which facilitates the cellular response to DNA damage. This subunit appears to be required for DNA binding. Mutations in this gene cause xeroderma pigmentosum complementation group E, a recessive disease that is characterized by an increased sensitivity to UV light and a high predisposition for skin cancer development, in some cases accompanied by neurological abnormalities. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 11-47238117-T-C is Benign according to our data. Variant chr11-47238117-T-C is described in ClinVar as [Benign]. Clinvar id is 1237094.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.695 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.580 AC: 88090AN: 151896Hom.: 27301 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
88090
AN:
151896
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.599 AC: 148264AN: 247400 AF XY: 0.609 show subpopulations
GnomAD2 exomes
AF:
AC:
148264
AN:
247400
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.662 AC: 965777AN: 1458322Hom.: 327454 Cov.: 38 AF XY: 0.661 AC XY: 479460AN XY: 725356 show subpopulations
GnomAD4 exome
AF:
AC:
965777
AN:
1458322
Hom.:
Cov.:
38
AF XY:
AC XY:
479460
AN XY:
725356
Gnomad4 AFR exome
AF:
AC:
12757
AN:
33446
Gnomad4 AMR exome
AF:
AC:
25035
AN:
44240
Gnomad4 ASJ exome
AF:
AC:
20342
AN:
26096
Gnomad4 EAS exome
AF:
AC:
10213
AN:
39654
Gnomad4 SAS exome
AF:
AC:
46249
AN:
85898
Gnomad4 FIN exome
AF:
AC:
31453
AN:
53290
Gnomad4 NFE exome
AF:
AC:
776429
AN:
1109662
Gnomad4 Remaining exome
AF:
AC:
39212
AN:
60272
Heterozygous variant carriers
0
17588
35176
52764
70352
87940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
19308
38616
57924
77232
96540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.580 AC: 88160AN: 152014Hom.: 27322 Cov.: 31 AF XY: 0.571 AC XY: 42437AN XY: 74300 show subpopulations
GnomAD4 genome
AF:
AC:
88160
AN:
152014
Hom.:
Cov.:
31
AF XY:
AC XY:
42437
AN XY:
74300
Gnomad4 AFR
AF:
AC:
0.385417
AN:
0.385417
Gnomad4 AMR
AF:
AC:
0.628324
AN:
0.628324
Gnomad4 ASJ
AF:
AC:
0.773068
AN:
0.773068
Gnomad4 EAS
AF:
AC:
0.253968
AN:
0.253968
Gnomad4 SAS
AF:
AC:
0.534647
AN:
0.534647
Gnomad4 FIN
AF:
AC:
0.57259
AN:
0.57259
Gnomad4 NFE
AF:
AC:
0.70048
AN:
0.70048
Gnomad4 OTH
AF:
AC:
0.648341
AN:
0.648341
Heterozygous variant carriers
0
1779
3559
5338
7118
8897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
728
1456
2184
2912
3640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1549
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Xeroderma pigmentosum, group E Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at